Position in NGEN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$448,050
-$309,720 QoQ
Shares Held
217,500
+8.2% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 62 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PFG Investments, LLC holds $9,610,443 across 28 Biotechnology names. NGEN ranks #7 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ADMA |
Adma Biologics, Inc.
|
270,178 | $2,261,389 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,219 | $1,102,243 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
13,125 | $977,550 | |
| 4 | ARDX |
Ardelyx, Inc.
|
137,660 | $702,066 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
30,600 | $519,282 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
8,587 | $468,334 | |
| 7 | NGEN |
Nervgen Pharma Corp.
This page
|
217,500 | $448,050 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
1,455 | $414,631 |
All Filings in NGEN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $448,050 | 217,500 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $757,770 | 201,000 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||